Please assess the completion status of the following clinical trial:

Trial Title: Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemotherapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. 18 years old to less than 65 years old~2. Subjects with malignancy must be receiving chemotherapy~3. Medically stable~4. Able to understand and willingness to sign a written informed consent~5. Able to comply with study procedures~6. Life expectancy of more than 3 months~7. Adequate organ function:~   * ANC \>1000/mm3~  * Platelet \>100,000/uL~  * Creatinine \<2 mg/dL~  * AST and ALT \<3 times the ULN~Exclusion Criteria:~1. Allergy to eggs~2. Prior allergy to Influenza Vaccine~3. History of Guillain-Barre Syndrome~4. Current febrile illness~5. Other immunosuppressive disease (recipients of solid organ transplant, uncontrolled HIV)~6. Autologous or Allogenic Stem Cell Transplant with in a year~7. Current immunotherapy or immunochemotherapy in the last 6 months (rituximab or ofatumumab)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- High-Dose Influenza Vaccine (Type: EXPERIMENTAL): None
- Standard Trivalent Influenza Vaccine (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).